Lumenis Introduces triLIFT 2.0™
In the rapidly evolving landscape of aesthetic treatments, Lumenis Be Ltd. has taken a significant leap forward with the introduction of triLIFT 2.0™, a groundbreaking platform that focuses on dynamic muscle stimulation for both the face and body. As non-surgical aesthetic solutions gain traction, this innovative system targets the underlying muscle structure, addressing one of the key causes of aging.
Addressing Age-Related Muscle Loss
Aging brings a host of changes, notably the gradual decline in skeletal muscle mass, which can lead to sagging skin, loss of jawline definition, and reduced firmness in various body parts. Research indicates that individuals lose between 3-8% of their muscle mass per decade after the age of 30. With 70% of patients desiring natural-looking results, the need for effective muscle stimulation methods has never been more evident. Moreover, the recent rise in GLP-1 medications, which can lead to substantial muscle mass loss and skin laxity, has amplified the need for aesthetic solutions that encourage muscle toning and lifting.
The Innovation Behind triLIFT 2.0™
The triLIFT 2.0™ combines Lumenis' advanced technologies—Dynamic Muscle Stimulation technology™ (DMSt) and FibroBoost™—to provide a comprehensive treatment. The DMSt is designed to deliver intense muscle contractions that surpass normal voluntary exercise, targeting deep muscle layers to restore density, improve tone, and achieve lifting effects. For optimal results, the treatment involves around five sessions for facial treatments and six for body treatments, all spaced one week apart.
Clinical studies have revealed promising outcomes:
- - A full 100% of body-treatment patients observed measurable improvement after one month.
- - 94% of participants noted enhancements in facial muscle tone and lifting.
- - A remarkable 68% reduction in the severity of body cellulite dimpling was reported after four treatments.
- - 90% of patients experienced improvements in facial skin tightness.
The Role of FibroBoost™
FibroBoost™ adds another layer to the triLIFT 2.0 experience by employing ultrathin electrodes, comparable to the thickness of a human hair, alongside a double pulse technology that gently penetrates the skin through RF to stimulate regeneration of collagen, elastin, and hyaluronic acid. This pioneering technology not only activates the muscles but also enhances skin quality, offering a triple-action approach that improves both the muscle structure and the skin surface.
Expert Insights
Dr. James Chelnis, a leading ophthalmic plastic and reconstructive surgeon, emphasized the comprehensive enhancements brought by triLIFT 2.0, stating, "This approach fundamentally redefines our methods for treating both face and body. We are not only achieving noticeable lifting results but also bolstering body contour, firmness, and tone in a manner that appears natural and is long-lasting without the need for surgery."
Itay Mayer, Chief Commercial Officer at Lumenis, further emphasized their commitment to innovation in the aesthetics industry, especially as they celebrate their 60th anniversary. He noted, "We are transitioning the conversation from merely addressing skin to focusing on deeper, more substantial rejuvenation that commences at the foundational structure—the muscle. This development is pivotal for many practitioners and patients awaiting effective solutions."
Presentation and Availability
The triLIFT 2.0 will be showcased at the upcoming 2026 AAD Annual Meeting, scheduled from March 27 to 31, at Lumenis Booth#1123. For those in the aesthetic practice realm, the system is now available for immediate implementation.
About Lumenis
For over 60 years, Lumenis has been a frontrunner in the medical aesthetic and eye care sectors, specializing in the development of innovative energy-based technologies, including lasers, Intense Pulsed Light (IPL), and Radiofrequency (RF). Their pioneering products have continually set new standards for medical treatments and have revolutionized traditional methods, opening doors to new treatment arenas.
For more details, visit
triLift.